Japan Oncology Information Systems Market Size, Share, and COVID-19 Impact Analysis, By Product (Software and Services), By Application (Radiation Oncology, Medical Oncology, and Surgical Oncology), By End User (Hospitals and Diagnostic Imaging Centers, Ablation Care Centers and Cancer Care Centers, Government Institutions, and Research Facilities), and Japan Oncology Information Systems Market Insights, Industry Trend, Forecasts to 2035

Japan Oncology Information System Market Insights Forecast ti 2035

• The Japan Oncology Information System Market Size was Estimitaed at USD 104.8 Million in 2024
• The Market Size is Expected to grow at a CAGR of around 8.31% from 2025 to 2035
• The Japan Oncology Information System Market Size Expected to Reach USD 252.3 Million by 2035

Market Overview

The Japan oncology information systems (OIS) market refers to advanced computer systems that consolidate cancer information, including electronic health records, treatment plans, imaging, and laboratory results, to facilitate care coordination, treatment accuracy, and clinical work processes in oncology departments. Implemented in radiation, medical, and surgical oncology, OIS assists multidisciplinary groups, ensures compliance with regulatory requirements, and assists in research and quality assurance. The strengths of Japan, its mature healthcare infrastructure, high healthcare expenditures, and widespread electronic medical record adoption offer a solid foundation for the deployment of OIS. Key opportunities are AI-powered predictive planning, cloud solutions, remote monitoring, and mHealth integration. Growth stems from Japan's increasing cancer incidence, demand for effective patient data management, and movement towards personalized medicine with the incorporation of genomics. Government initiatives through digital healthcare policies, Japan's Digital Agencies digitization programs, and COVID-19-led telemedicine growth further accelerate market expansion.

Report Coverage

This research report categorizes the market for the Japan oncology information systems market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan oncology information systems market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan oncology information systems market.

Driving Factors

The Japan oncology information systems market is fuelled by growing cancer incidence, accelerating demand for effective patient data management, and enhancing adoption of personalized medicine. Improvements in healthcare IT infrastructure, use of AI and big data in treatment planning, and increasing adoption of telemedicine and remote monitoring also drive market growth. The robust digital health ecosystem and government support for the digitization of healthcare in Japan also boost the adoption of oncology information systems in cancer care centers and hospitals.

Restraining Factors

The Japan oncology information systems market is hindered by high implementation and maintenance prices, privacy and security of data, and interoperability among platforms. These hindrances limit adoption rates, particularly among small healthcare institutions with few technical and financial resources.

Market Segmentation

The Japan oncology information systems market share is classified into product, application, and end user.

• The software segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan oncology information systems market is segmented by product into software and services.  Among these, the software segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to its critical function in facilitating the management of cancer patient data, treatment planning, and clinical decision-making support. The use of AI, big data analytics, and cloud technologies also increases software adoption, improving diagnostic accuracy and operational efficiency.

• The medical oncology segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan oncology information systems market is segmented by application into radiation oncology, medical oncology, and surgical oncology. Among these, the medical oncology segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is attributed to the growing application of systemic treatments like chemotherapy, immunotherapy, and targeted therapy, which necessitate extensive data management and treatment planning. OIS platforms make patient information, treatment protocols, and clinical decision support easy to integrate, improving the accuracy and efficiency of medical oncology practice.

• The hospitals and diagnostic imaging centers segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan oncology information systems market is segmented by end user into hospitals and diagnostic imaging centers, ablation care centers and cancer care centers, government institutions, and research facilities. Among these, the hospitals and diagnostic imaging centers segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is owing to their large patient volumes and central role in cancer treatment and diagnosis. Government plans to modernize healthcare infrastructure and the growing incidence of cancer also propel demand for sophisticated OIS within these facilities.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan oncology information systems market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Recent Developments:

• In November 2023, Accuray Incorporated launched its VitalHold package in Japan, improving the Radixact System with surface-guided radiation therapy (SGRT) for advanced breast cancer care. With over 100 Radixact units in clinical use across Japan, this innovation expands Accuray’s offerings and strengthens its position in the Japanese radiotherapy market, advancing cancer treatment outcomes.

List of key Companies 

• Nihon Kohden Corporation
• Fujirebio
• Koninklijke philips N. V
• Canon Medical System Corporation
• Nichil Gakkan
• Cerner Corporation
• Siemens Healthneers
• Mckesson Corporation

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan oncology information systems market based on the below-mentioned segments:

Japan Oncology Information Systems Market, By Product

• Software
• Services

Japan Oncology Information Systems Market, By Application

• Radiation Oncology
• Medical Oncology
• Surgical Oncology

Japan Oncology Information Systems Market, By End User

• Hospitals and Diagnostic Imaging Centers
• Ablation Care Centers and Cancer Care Centers
• Government Institutions
• Research Facilities